Company Registration No. 15576518 (England and Wales)
BOUNCE MEDICAL COMMUNICATIONS LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
TWP Accounting LLP
Chartered Accountants
The Old Rectory
Church Street
Weybridge
Surrey
KT13 8DE
BOUNCE MEDICAL COMMUNICATIONS LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
BOUNCE MEDICAL COMMUNICATIONS LTD
Company Registration No. 15576518
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
7,571
3,090
Current assets
Debtors
4
248,927
88,452
Cash at bank and in hand
126,457
98,433
375,384
186,885
Creditors: amounts falling due within one year
5
(308,157)
(141,897)
Net current assets
67,227
44,988
Net assets
74,798
48,078
Capital and reserves
Called up share capital
6
2
2
Profit and loss reserves
74,796
48,076
Total equity
74,798
48,078

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 10 August 2026 and are signed on its behalf by:
K Moores
K Elderton-Brown
Director
Director
BOUNCE MEDICAL COMMUNICATIONS LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
1
Accounting policies
Company information

Bounce Medical Communications Ltd is a private company limited by shares incorporated in England and Wales. The registered office is The Old Rectory, Church Street, Weybridge, Surrey, United Kingdom, KT13 8DE.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
3 year straight line
Computers
3 year straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

BOUNCE MEDICAL COMMUNICATIONS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 3 -
1.5
Financial instruments
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
10
3
BOUNCE MEDICAL COMMUNICATIONS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 4 -
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2025
3,642
Additions
6,794
At 31 December 2025
10,436
Depreciation and impairment
At 1 January 2025
552
Depreciation charged in the year
2,313
At 31 December 2025
2,865
Carrying amount
At 31 December 2025
7,571
At 31 December 2024
3,090
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
248,054
82,560
Other debtors
873
5,892
248,927
88,452
5
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
13,085
308
Taxation and social security
108,830
16,966
Other creditors
186,242
124,623
308,157
141,897
6
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
2
2
2
2
BOUNCE MEDICAL COMMUNICATIONS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
7
Related party transactions

At the balance sheet date the company owed the director K Elderton-Brown £490 (2024 - £Nil).

At the balance sheet date the company owed the director K Moores £20 (2024 - £Nil).

2025-12-31 2025-01-01 false false false 10 August 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity K Moores K Elderton-Brown 15576518 2025-01-01 2025-12-31 15576518 2025-12-31 15576518 2024-12-31 15576518 core:OtherPropertyPlantEquipment 2025-12-31 15576518 core:OtherPropertyPlantEquipment 2024-12-31 15576518 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 15576518 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 15576518 core:CurrentFinancialInstruments 2025-12-31 15576518 core:CurrentFinancialInstruments 2024-12-31 15576518 core:ShareCapital 2025-12-31 15576518 core:ShareCapital 2024-12-31 15576518 core:RetainedEarningsAccumulatedLosses 2025-12-31 15576518 core:RetainedEarningsAccumulatedLosses 2024-12-31 15576518 core:ShareCapitalOrdinaryShareClass1 2025-12-31 15576518 core:ShareCapitalOrdinaryShareClass1 2024-12-31 15576518 bus:Director1 2025-01-01 2025-12-31 15576518 bus:Director2 2025-01-01 2025-12-31 15576518 core:FurnitureFittings 2025-01-01 2025-12-31 15576518 core:ComputerEquipment 2025-01-01 2025-12-31 15576518 2024-03-19 2024-12-31 15576518 core:OtherPropertyPlantEquipment 2024-12-31 15576518 core:OtherPropertyPlantEquipment 2025-01-01 2025-12-31 15576518 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 15576518 bus:OrdinaryShareClass1 2025-12-31 15576518 bus:OrdinaryShareClass1 2024-12-31 15576518 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 15576518 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 15576518 bus:FRS102 2025-01-01 2025-12-31 15576518 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 15576518 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP